Introduction Selective serotonin reuptake inhibitors (SSRIs) and, to a lesser extent, serotonin‐
norepinephrine reuptake inhibitors (SNRIs) are the cornerstone of pharmacotherapy for …

Background Anxiety and related disorders are among the most common mental disorders,
with lifetime prevalence reportedly as high as 31%. Unfortunately, anxiety disorders are …

Introduction: Generalized anxiety disorder (GAD) often begins during adolescence or early
adulthood and persists throughout the lifespan. Randomized controlled trials support the …

This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

Abstract Background Generalized Anxiety Disorder (GAD) is one of the most common
anxiety disorders treated in primary care, yet current therapies have limited efficacy and …

Objectives To examine the risk of relapse and time to relapse after discontinuation of
antidepressants in patients with anxiety disorder who responded to antidepressants, and to …

ABSTRACT Introduction Generalized Anxiety Disorder (GAD) is a common psychiatric
condition, characterized by the presence of general apprehensiveness and excessive worry …

Background Depression and anxiety are the most frequent indication for which
antidepressants are prescribed. Long‐term antidepressant use is driving much of the …

Both major depressive disorder and the anxiety disorders are major causes of disability and
markedly contribute to a significant global burden of the disease worldwide. In part because …

Introduction: Modest response and remission rates for the selective serotonin reuptake
inhibitors and the serotonin-norepinephrine reuptake inhibitors, coupled with mounting …